Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345(5):340–50.

Article  CAS  PubMed  Google Scholar 

Cici D, Corrado A, Rotondo C, Cantatore FP. Wnt signaling and biological therapy in rheumatoid arthritis and spondyloarthritis. Int J Mol Sci. 2019;20(22):5552.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Basta F, Fasola F, Triantafyllias K, Schwarting A. Systemic lupus erythematosus (SLE) therapy: the old and the new. Rheumatol Ther. 2020;7(3):433–46.

Article  PubMed  PubMed Central  Google Scholar 

Burn P. Type 1 diabetes. Nat Rev Drug Discov. 2010;9(3):187.

Article  CAS  PubMed  Google Scholar 

Dobson R, Giovannoni G. Multiple sclerosis—a review. Eur J Neurol. 2019;26(1):27–40.

Article  CAS  PubMed  Google Scholar 

Ng QX, Soh AY, Loke W, Lim DY, Yeo WS. The role of inflammation in irritable bowel syndrome (IBS). J Inflamm Res. 2018;21:345–9.

Article  Google Scholar 

Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, et al. Expansion of intestinal Prevotellacopri correlates with enhanced susceptibility to arthritis. elife. 2013;2:e01202.

Article  PubMed  PubMed Central  Google Scholar 

Sadeghpour Heravi F, Hu H. Bifidobacterium: host–microbiome interaction and mechanism of action in preventing common gut-microbiota-associated complications in preterm infants: a narrative review. Nutrients. 2023. https://doi.org/10.3390/nu15030709.

Article  PubMed  PubMed Central  Google Scholar 

Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538–41.

Article  CAS  PubMed  ADS  Google Scholar 

Wu H-J, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32(6):815–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armstrong D, Dregan A, Ashworth M, White P, McGee C, de Lusignan S. Influence of prior antibiotic use on risk of rheumatoid arthritis: case control study in general practice. Rheumatology. 2020;59(6):1281–7.

Article  PubMed  Google Scholar 

Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 2012;64(5):625–39.

Article  CAS  Google Scholar 

Law SC, Street S, Yu C-HA, Capini C, Ramnoruth S, Nel HJ, et al. T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis Res Ther. 2012;14(3):1–12.

Article  Google Scholar 

Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13(4):260–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koh JH, Lee EH, Cha KH, Pan C-H, Kim D, Kim W-U. Factors associated with the composition of the gut microbiome in patients with established rheumatoid arthritis and its value for predicting treatment responses. Arthritis Res Ther. 2023;25(1):32.

Article  PubMed  PubMed Central  Google Scholar 

Azzouz DF, Chen Z, Izmirly PM, Chen LA, Li Z, Zhang C, Mieles D, Trujillo K, Heguy A, Pironti A, Putzel GG. Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares. Ann Rheum Dis. 2023;82(10):1315–27.

Article  CAS  PubMed  Google Scholar 

Viatte S, Rigby WFC. HLA and other susceptibility genes in rheumatoid arthritis. 2019;1–4.

Berer K, Krishnamoorthy G. Microbial view of central nervous system autoimmunity. FEBS Lett. 2014;588(22):4207–13.

Article  CAS  PubMed  Google Scholar 

Jangi S, Gandhi R, Cox LM, Li N, Von Glehn F, Yan R, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016;7(1):12015.

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci. 2017;114(40):10713–8.

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

Liu X, Zou Q, Zeng B, Fang Y, Wei H. Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis. Curr Microbiol. 2013;67:170–6.

Article  CAS  PubMed  Google Scholar 

Chen BD, Jia XM, Xu JY, Zhao LD, Ji JY, Wu BX, Fei YY, Yang HX, Chen H, Zuo XX, Li H. Proinflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus. Biorxiv. 2019;621995.

Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6(263):263ra158-263ra158.

Article  PubMed  PubMed Central  Google Scholar 

Golpour F, Abbasi-Alaei M, Babaei F, Mirzababaei M, Parvardeh S, Mohammadi G, et al. Short chain fatty acids, a possible treatment option for autoimmune diseases. Biomed Pharmacother. 2023;163:114763.

Article  CAS  PubMed  Google Scholar 

Bellocchi C, Fernández-Ochoa Á, Montanelli G, Vigone B, Santaniello A, Quirantes-Piné R, et al. Identification of a shared microbiomic and metabolomic profile in systemic autoimmune diseases. J Clin Med. 2019;8(9):1291.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Liao X, Sparks JB, Luo XM. Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol. 2014;80(24):7551–60.

Article  PubMed  PubMed Central  ADS  Google Scholar 

Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases. In Seminars in immunopathology. Springer Berlin Heidelberg; 2019; 41, pp. 283–97.

De Groot P, Nikolic T, Pellegrini S, Sordi V, Imangaliyev S, Rampanelli E, et al. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. Gut. 2021;70(1):92–105.

Article  PubMed  Google Scholar 

Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity. 2017;46(4):562–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiao Y, Wu L, Huntington ND, Zhang X. Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases. Front Immunol. 2020;11:282.

Article  CAS  PubMed  PubMed Central  Google Scholar 

López P, de Paz B, Rodríguez-Carrio J, Hevia A, Sánchez B, Margolles A, et al. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci Rep. 2016;6(1):24072.

Article  PubMed  PubMed Central  ADS  Google Scholar 

Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78(7):947–56.

Article  CAS  PubMed  Google Scholar 

Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV, Murray J, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016;8(1):1–14.

Article  Google Scholar 

Chiang H-I, Li J-R, Liu C-C, Liu P-Y, Chen H-H, Chen Y-M, et al. An association of gut microbiota with different phenotypes in Chinese patients with rheumatoid arthritis. J Clin Med. 2019;8(11):1770.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shin C, Kim Y-K. Autoimmunity in microbiome-mediated diseases and novel therapeutic approaches. Curr Opin Pharmacol. 2019;49:34–42.

Article  CAS  PubMed  Google Scholar 

Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol. 1993;123(6):1777–88.

Article  CAS  PubMed  Google Scholar 

Buscarinu M, Romano S, Mechelli R, Pizzolato Umeton R, Ferraldeschi M, Fornasiero A, et al. Intestinal permeability in relapsing-remitting multiple sclerosis. Neurotherapeutics. 2018;15:68–74.

Article  CAS  PubMed  Google Scholar 

Harbison JE, Roth-Schulze AJ, Giles LC, Tran CD, Ngui KM, Penno MA, et al. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: a prospective cohort study. Pediatr Diabetes. 2019;20(5):574–83.

CAS  PubMed